AVITA Medical, Inc. Cash Equivalents, at Carrying Value
AVITA Medical, Inc. (RCEL) had Cash Equivalents, at Carrying Value of $7.40 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:CashEquivalentsAtCarryingValue · last filed 2026-08-06
- 2026-06-30: Cash Equivalents, at Carrying Value $7.40M.
- 2026-03-31: Cash Equivalents, at Carrying Value $6.10M.
- 2025-12-31: Cash Equivalents, at Carrying Value $8.40M.
- 2025-09-30: Cash Equivalents, at Carrying Value $8.30M.
| Period end | Cash Equivalents, at Carrying Value |
|---|---|
| 2026-06-30 | $7.40M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $6.10M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $8.40M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $8.30M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $10.60M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $12.90M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $11.70M 10-K · filed 2026-02-12 |
| 2024-09-30 | $13.30M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $10.80M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $12.00M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $11.40M 10-K · filed 2025-02-13 |
| 2023-09-30 | $46.40M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $31.70M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $24.80M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $14.10M 10-K · filed 2024-02-22 |
| 2022-09-30 | $17.40M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $29.70M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $16.60M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $51.10M 10-K · filed 2023-02-23 |
| 2021-09-30 | $58.00M 10-Q · filed 2021-11-08 |
| 2021-06-30 | $56.50M 10-K · filed 2023-02-23 |
| 2020-06-30 | $0.00 10-KT · filed 2022-02-28 |